Skip to content

Fire Erowid

EC: Erowid Center, PO Box 1116, Grass Valley, CA, 95945, USA.

13 papers in the library · 910 citations · publishing 2010-2025

Papers

Cessation and reduction in alcohol consumption and misuse after psychedelic use

Journal of Psychopharmacology May 14, 2019 Albert Garcia-Romeu, Alan K Davis, Fire Erowid et al. 286 citations

In a survey of 343 people who had problematic alcohol use for an average of seven years and then used psychedelics in non-clinical settings, 83% no longer met criteria for alcohol use disorder after the experience. Most respondents were White males in the USA who took moderate or high doses of LSD or psilocybin. They rated the experience as highly meaningful and insightful, and 28% said changes in life priorities or values helped reduce alcohol misuse. Greater dose, insight, mystical-type effects, and personal meaning were linked to larger reductions in drinking. The results suggest naturalistic psychedelic use may reduce problematic alcohol use, supporting further research into psychedelic-assisted treatment.

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

Frontiers in Psychiatry January 22, 2020 Earth Erowid, Fire Erowid, Albert Garcia‐romeu et al. 155 citations

A cross-sectional, self-report survey found that people who use psychedelics reported reductions in problematic substance use, including alcohol, opioids, and stimulants. The authors note that because the study is cross-sectional and relies on self-reports, it cannot determine whether psychedelics caused these changes. However, the results suggest a potential for psychedelics to reduce problematic substance use and support further clinical research into psychedelic-assisted treatment for substance use disorders.

The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports

Frontiers in Neuroscience January 22, 2018 Camila Sanz, Federico Zamberlán, Earth Erowid et al. 112 citations

Subjective reports of experiences under hallucinogens like LSD are semantically most similar to reports of high-lucidity dreams, while Datura (a deliriant) resembles low-lucidity dreams. Sedatives, stimulants, antipsychotics, and antidepressants rank lowest in similarity to dream reports. Frequent words across both dreams and hallucinogen experiences include perception-related terms ("see," "visual," "color"), emotion ("fear"), setting ("inside," "outside"), and family members ("mom," "dad"). The analysis confirms that hallucinogens produce experiences with the highest semantic similarity to dreams among all psychoactive substances.

Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports.

Consciousness and cognition March 1, 2019 Charlotte Martial, Héléna Cassol, Vanessa Charland-Verville et al. 98 citations

Near-death experiences (NDEs) share consistent features across cultures, suggesting a common neurobiological basis. Analyzing semantic similarity between about 15,000 reports from 165 psychoactive substances and 625 NDE narratives, the NMDA receptor antagonist ketamine produced reports most similar to NDEs, followed by Salvia divinorum and serotonergic psychedelics like DMT. The similarity was driven by concepts of self and environmental consciousness, as well as therapeutic, ceremonial, and religious aspects of drug use. Ketamine may serve as a safe experimental model for NDE phenomenology, and endogenous NMDA antagonists might be released near death.

The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines

Frontiers in Integrative Neuroscience November 1, 2018 Camila Sanz, Carla Pallavicini, Carla Pallavicini et al. 78 citations

Classic psychedelics produce a wide range of subjective effects influenced by the user's mindset and environment, and their common mechanism involves activation of the serotonin 5-HT2A receptor. The diversity of effects across different compounds may also stem from their binding affinities for multiple neurotransmitter receptors and transporters. By analyzing two binding affinity datasets alongside natural language processing of thousands of trip reports from Erowid's Experience Vaults, preliminary evidence showed that similarity in binding profiles across phenethylamines and tryptamines correlates with similarity in the language used to describe experiences.

Use patterns and self-reported effects of Salvia divinorum: an internet-based survey.

Drug and alcohol dependence October 1, 2010 Matthew J Baggott, Earth Erowid, Fire Erowid et al. 78 citations

A survey of 500 individuals who had used Salvia divinorum found that 92.6% typically smoked or vaporized the plant, with acute effects lasting about 14 minutes on average. Most participants (80.6%) said they would use it again, and 38.4% described the experience as unique. On at least one occasion, 25.8% reported persisting positive effects lasting 24 hours or more, often an increased sense of well-being, while 4.4% reported persisting negative effects, most commonly anxiety. These findings suggest that Salvia divinorum may produce subacute improvements in mood, which is unusual for a non-medically used drug.

Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports

Pharmacopsychiatry August 4, 2021 Sandeep M Nayak, Natalie Gukasyan, Frederick S Barrett et al. 67 citations

Combining classic psychedelics like LSD or psilocybin with the mood stabilizer lithium carries a high risk of seizures. In an analysis of 62 online reports of such combinations, 47% involved seizures and 18% resulted in bad trips; 39% required medical attention. In contrast, none of 34 reports combining psychedelics with the mood stabilizer lamotrigine involved seizures, and most lamotrigine reports (65%) indicated no effect on the psychedelic experience. The findings suggest that lithium, but not lamotrigine, may pose a significant seizure danger when taken with psychedelics, though further research is needed.

Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports

February 24, 2021 Sandeep M. Nayak, Natalie Gukasyan, Frederick S. Barrett et al. 10 citations preprint

Classic psychedelics such as LSD or psilocybin may pose a significant seizure risk for people taking the mood stabilizer lithium. Analysis of online reports found that 47% of 62 accounts of combining lithium with a psychedelic involved seizures, and an additional 18% resulted in bad trips; 39% required medical attention. In contrast, none of 34 reports of the mood stabilizer lamotrigine combined with a psychedelic involved seizures, and most lamotrigine reports (65%) indicated no effect on the psychedelic experience. The authors provisionally conclude that psychedelic use with lithium carries a seizure risk, warranting further research.

The influence of context on ayahuasca experiences: An analysis of experience reports

Journal of Psychedelic Studies September 1, 2019 Avery Sapoznikow, Zachary Walsh, Kenneth W. Tupper et al. 8 citations

Ayahuasca, a psychedelic brew used for centuries in the Amazon and now internationally, produces different subjective experiences depending on the context of use. Analyzing online reports, ceremonial settings that incorporate traditional Amazonian elements emphasize emotional and motivational features, while psychonautic use without such rituals highlights cognitive processes. The findings suggest that beneficial effects of ayahuasca may stem from affective processing and integration, implying that cross-cultural ceremonial use may offer advantages over psychonautic use, underscoring the importance of context in psychedelic experiences.

A qualitative analysis of the psychedelic mushroom come-up and come-down.

Npj mental health research February 7, 2025 Ari Brouwer, Joshua K Brown, Earth Erowid et al. 5 citations

Psychedelic therapy may work partly because of an overlooked temporal pattern: the initial 'come-up' phase often feels like an acute stress reaction, while the later 'come-down' phase brings positive feelings similar to recovery from illness or stress. A qualitative analysis of psilocybin experience reports from Erowid.org, using phenomenological, thematic content, and word frequency analysis, shows that negatively valenced states dominate the onset, and positively valenced states dominate the falling phase. This pattern helps explain how initially distressing altered states can ultimately resolve distress, with implications for therapeutic and theoretical understanding of psychedelic treatment.

A novel method for quantitative analysis of subjective experience reports: application to psychedelic visual experiences

Frontiers in Psychology December 6, 2024 Sean Noah, Earth Erowid, Fire Erowid et al. 5 citations

Psychedelic compounds like LSD, psilocybin, mescaline, and DMT can dramatically alter visual perception, but whether these visual effects consistently differ between substances is unclear. Using the large Erowid experience report dataset, researchers analyzed narrative self-reports for 103 psychoactive substances, including 30 psychedelics and 73 comparison substances. They used an AI embedding model to classify sentences describing visual effects. The proportion of visual-effect sentences varied significantly and consistently across substances, even among psychedelics. Further analysis of visual effect categories—such as movement, color, and pattern—also showed reliable variation. The findings indicate that different psychedelic substances have distinct propensities to affect vision and produce qualitatively different visual experiences.

The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s Journey

Research Square (Research Square) February 23, 2024 Ari Brouwer, Joshua K. Brown, Earth Erowid et al. 5 citations

Psychedelic therapy may work partly because its temporal structure mirrors the narrative arc of the Hero's Journey. A qualitative analysis of self-reported onset (comeup) and offset (comedown) phases of psilocybin experiences found that the comeup is more often characterized by negatively valenced feeling states, while the comedown is more often characterized by positively valenced feeling states resembling recovery from illness or adversity. This trajectory suggests that initially distressing altered states can ultimately resolve distress, offering a framework for understanding the therapeutic benefits of psychedelics.